Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design
Immunological Reviews · 2026
DOI: 10.1111/imr.70098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2026. Verfasst von Ilka Grewe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Infection Research and Vaccine Development (IIRVD), University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Hauptthemen laut MEDLINE: Viral Vaccines, Sex Characteristics, Genetic Vectors, Virus Diseases. Die Arbeit nennt 260 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation (DFG), German Centre for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Coalition for Epidemic Preparedness Innovations.
Abstract (Originalsprache)
Vaccination represents one of the most impactful public health achievements, preventing 3.5 to 5 million deaths annually according to estimates of the World Health Organization. Yet, recent outbreaks of emerging and reemerging infectious diseases highlight the need for rapid and strategic vaccine development using vaccine platforms technologies. Sexual dimorphism in vaccine‐induced immune responses has received significant attention in recent years. To ensure vaccine safety and efficacy across sexes, sex‐based differences should be considered in vaccine design, dosing, and regimen. Evidence on many traditional vaccines, such as the inactivated influenza vaccine, shows a female bias in innate and adaptive immune responses following vaccination. Thus, it has long been suggested that females universally develop stronger humoral and cellular immune responses to vaccines compared to males. However, compared to traditional vaccines, studies investigating sex differences following vaccination with next‐generation platforms, such as viral vector vaccines, remain limited. This review provides an overview of clinical observations of sex differences in responses to replication‐competent and replication‐deficient, recombinant and nonrecombinant viral vaccines. Additionally, we describe the current state of knowledge on mechanisms of sex‐based differences in immune responses and possible implications for future vaccine design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Infection Research and Vaccine Development (IIRVD), University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany.
- First Department of Medicine, Division of Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Bernhard-Nocht-Institute for Tropical Medicine, Department for Clinical Immunology of Infectious Diseases, Hamburg, Germany.
- German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
ORCID-Profile: Marylyn Martina Addo
Förderung
- German Research Foundation (DFG)
- German Centre for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems
- Coalition for Epidemic Preparedness Innovations
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Grewe, I., Zoran, T., & Addo, M. M. (2026). Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design. Immunological Reviews. https://doi.org/10.1111/imr.70098
Vancouver
Grewe I, Zoran T, Addo MM. Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design. Immunological Reviews. 2026. doi:10.1111/imr.70098
BibTeX
@article{Grewe2026,
author = {Grewe, Ilka and Zoran, Tamara and Addo, Marylyn Martina},
title = {Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design},
journal = {Immunological Reviews},
year = {2026},
doi = {10.1111/imr.70098}
}
EUVIMED